BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9496191)

  • 1. Factors involved in the rate of fall of thyroid stimulating hormone in treated hypothyroidism.
    Raza J; Hindmarsh PC; Brook CG
    Arch Dis Child; 1997 Dec; 77(6):526-7. PubMed ID: 9496191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis on factors affecting suppression of thyroid-stimulating hormone in treated congenital hypothyroidism.
    Ng SM; Wong SC; Isherwood DM; Smith CS; Didi M
    Horm Res; 2004; 62(5):245-51. PubMed ID: 15499223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal assessment of L-thyroxine therapy for congenital hypothyroidism.
    Germak JA; Foley TP
    J Pediatr; 1990 Aug; 117(2 Pt 1):211-9. PubMed ID: 2380819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital hypothyroidism. The effect of stopping treatment at 3 years of age.
    Davy T; Daneman D; Walfish PG; Ehrlich RM
    Am J Dis Child; 1985 Oct; 139(10):1028-30. PubMed ID: 4036889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The key role of newborn thyroid scintigraphy with isotopic iodide (123I) in defining and managing congenital hypothyroidism.
    Schoen EJ; Clapp W; To TT; Fireman BH
    Pediatrics; 2004 Dec; 114(6):e683-8. PubMed ID: 15574601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal screening for hypothyroidism at a university hospital in Thailand.
    Thaithumyanon P; Srivuthana S; Poshyachinda M
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():25-7. PubMed ID: 11400772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human TSH testing is a valuable tool for differential diagnosis of congenital hypothyroidism during L-thyroxine replacement.
    Fugazzola L; Persani L; Mannavola D; Reschini E; Vannucchi G; Weber G; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2003 Aug; 59(2):230-6. PubMed ID: 12864801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient neonatal 'athyreosis' resulting from thyrotropin-binding inhibitory immunoglobulins.
    Connors MH; Styne DM
    Pediatrics; 1986 Aug; 78(2):287-90. PubMed ID: 2874542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism.
    Fisher DA; Schoen EJ; La Franchi S; Mandel SH; Nelson JC; Carlton EI; Goshi JH
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2722-7. PubMed ID: 10946871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of TSH in congenital hypothyroidism is significantly related to serum levels and dosage of thyroxine.
    Brown JJ; Datta V; Sutton AJ; Swift PG
    Horm Res; 2003; 59(2):85-90. PubMed ID: 12589112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of etiology to treatment in congenital hypothyroidism.
    Hanukoglu A; Perlman K; Shamis I; Brnjac L; Rovet J; Daneman D
    J Clin Endocrinol Metab; 2001 Jan; 86(1):186-91. PubMed ID: 11231999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Academy of Pediatrics, American Thyroid Association: Newborn screening for congenital hypothyroidism: recommended guidelines.
    Pediatrics; 1987 Nov; 80(5):745-9. PubMed ID: 3670979
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for congenital hypothyroidism with specimen collection at two time periods: results of the Northwest Regional Screening Program.
    LaFranchi SH; Hanna CE; Krainz PL; Skeels MR; Miyahira RS; Sesser DE
    Pediatrics; 1985 Nov; 76(5):734-40. PubMed ID: 3932955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated threshold for thyrotropin suppression in congenital hypothyroidism.
    Schultz RM; Glassman MS; MacGillivray MH
    Am J Dis Child; 1980 Jan; 134(1):19-20. PubMed ID: 7350783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tc]-99m thyroid scintigraphy in congenital hypothyroidism screening program.
    Iranpour R; Hashemipour M; Amini M; Talaei SM; Kelishadi R; Hovsepian S; Haghighi S; Khatibi Kh
    J Trop Pediatr; 2006 Dec; 52(6):411-5. PubMed ID: 16943215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum thyroxine and thyroid stimulating hormone concentrations after treatment of congenital hypothyroidism.
    Abusrewil SS; Tyfield L; Savage DC
    Arch Dis Child; 1988 Nov; 63(11):1368-71. PubMed ID: 3202645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head circumference and linear growth during the first 3 years in treated congenital hypothyroidism in relation to aetiology and initial biochemical severity.
    Ng SM; Wong SC; Didi M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):155-9. PubMed ID: 15212659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma thyroid stimulating hormone in treated congenital hypothyroidism: relation to severity of hypothyroidism, plasma thyroid hormone status, and daily dose of thyroxine.
    Grant DB; Fuggle PW; Smith I
    Arch Dis Child; 1993 Nov; 69(5):555-8. PubMed ID: 8257174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound appearance of thyroid tissue in hypothyroid infants.
    Ogawa E; Kojima-Ishii K; Fujiwara I
    J Pediatr; 2008 Jul; 153(1):101-4. PubMed ID: 18571545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid-stimulating hormone, prolactin, and growth hormone response to thyrotropin-releasing hormone in treated children with congenital hypothyroidism.
    Sack J; Shafrir Y; Urbach D; Amado O
    Pediatr Res; 1985 Oct; 19(10):1037-9. PubMed ID: 3932951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.